Investors pursue Trinity Biotech over failed test kit
Company’s share price fell 50% after filing for heart attack diagnosis product withdrawn
Profit drops at pharmaceutical firm Trinity Biotech
Lower revenues and tighter gross margins were attributed with causing the drop
Trinity Biotech records 63% drop in pretax profit
Company says first quarter typically represents its lowest revenue quarter
Trinity Biotech slips into the red with third quarter loss
Company says latest results not impacted by withdrawal of US filing or facility closure
Jorcon incurs net loss of €2.5m as liabilities grow
Shareholders servicing Dublin property company loan
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Election 2024
Full general election coverage including analysis and results for all 43 constituencies
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices